(Q46388612)

English

Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

Peripheral and central blood pressure responses of combination aliskiren/hydrochlorothiazide and amlodipine monotherapy in African American patients with stage 2 hypertension: the ATLAAST trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

author name string

Keith C Ferdinand

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

James Pool

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

Richard Weitzman

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

Das Purkayastha

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

Raymond Townsend

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

publication date

18 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

13

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

366-375

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Racial differences in aortic stiffness in normotensive and hypertensive adults

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Arterial stiffness is greater in African Americans than in whites: evidence from the Forsyth County, North Carolina, ARIC cohort.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Ethnic differences in vascular stiffness and relations to hypertensive target organ damage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Central blood pressure measurements and antihypertensive therapy: a consensus document

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Racial differences in central blood pressure and vascular function in young men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Hypertension-Related Morbidity and Mortality in African Americans?Why We Need to Do Better

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Management of hypertension in ethnic minorities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Race-based therapy for hypertension: possible benefits and potential pitfalls

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

From black and white to shades of gray: race and renin-angiotensin system blockade

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Renin inhibition: what are the therapeutic opportunities?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Associati

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: Evidence for specific class-effects of antihypertensive drugs on pressure amplification

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Effect of different antihypertensive drug classes on central aortic pressure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Increased Vascular Adrenergic Vasoconstriction and Decreased Vasodilation in Blacks

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2010.00416.X

21 January 2018

Identifiers

10.1111/J.1751-7176.2010.00416.X

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/21545398

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46388612&oldid=2109169088"